Scientists were recently able to stop advanced-stage cancers in mice by using implanted "drug factories," and this new type of treatment only takes a few days to take effect.
Whereas it will take time for this approach to get tested and work in humans, the signs are promising that there's a new and powerful approach to tackle mesothelioma, an aggressive form of lung cancer, a ScienceAlert report specified.
The drug factories are composed of small alginate beads, each only 1.5 millimeters wide, designed to generate continuous blasts of interleukin-2 or IL-2.
According to Dr. Bryan Burt, a thoracic surgeon and surgical oncologist from the Baylor College of Medicine, this natural compound activates the white blood cells of the body to fight tumors.
'Plural Space'
"This is a very aggressive malignancy of the lining of the lungs," Dr. Burt explained, adding that it is very difficult to completely treat through surgical resection.
In other words, there is frequently residual disease left behind. More so, treating this residual disease with local immunotherapy, the local delivery of comparatively high immunotherapy doses to the pleural space, is an attractive way of treating the disease.
Essentially, the "plural space" refers to the tissue layer covering the lungs, where mesothelioma tumors are also developing. Part of the treatment's success is down to the way that it is locally targeted.
In their study published in the Clinical Cancer Research, the researchers incorporated the implants with what's known today as a checkpoint inhibitor, a drug type that's not directly tackling cancer but trains the immune system to better deidentify and remove cancer cells. In this approach, targeting the PD-1 protein was used.
Drug Factory Implants
On their own, the drug factory implants were able to wipe out the tumors in more than half of the animals tested. When they were combined with the checkpoint inhibitor on seven mouse models, the tumors were destroyed completely.
Describing their data, Burt said they show that delivery of these immunotherapy particles, regionally, to these mice with mesothelioma has quite provocative and very effective responses to treatment.
From the findings that the researchers obtained, they are confident that there is a good chance that the treatment could effectively train the memory T cells in the body too, to fight mesothelioma, should it recur.
IL-2 Treatments
Whereas IL-2 treatments have been shown efficacy, they can also come with some severe side effects.
This is another area where the target of the new treatment help since it's limiting the parts of the body exposed to the drug.
Furthermore, the same drug bead factory approach has been used previously by some of the same researchers to try and treat ovarian cancer, and human clinical trials for that therapy are scheduled to begin in the coming months. It is a therapy that has the potential "to go way beyond mesothelioma," a similar Qudach report said.
According to Texas-based Rice University's Amanda Nash, from the start, their objective was to develop a platform treatment that can be used for multiple different types of immune systems or different cancer types.
A report about the drug company implant is shown on The Study Finds Guy's YouTube video below:
RELATED ARTICLE : No Food Intake for 24 Hours Eliminates Heart Muscle Damage Increasing Survival of Chemotherapy Patients
Check out more news and information on Cancer in Science Times.
